Bionexus Gene Lab Corp BGLC Stock Forecast
AI-powered price prediction and analysis for Bionexus Gene Lab Corp · Alpha · vs marketSwitch to Total
See BGLC's Exact Price Target · Create a free account and follow this stock to unlock its full AI forecast — 3 stocks free.
Price Chart
Key Statistics
About Bionexus Gene Lab Corp
Bionexus Gene Lab Corp (BGLC) operates within the Industrial Applications and Services sector, specifically in the Services-Medical Laboratories industry.
Latest News
- BioNexus Launches BGLC 1Lab Pilot for GeneMatrix Workflows at MRNA Scientific
- BioNexus Gene Lab Corp. (Nasdaq: BGLC) and Fidelion Diagnostics Execute Exclusive Southeast Asia License for VitaGuard™ MRD Platform as Part of Strategic Alliance with ...
- BioNexus Launches New Corporate Website with Expanded Business and Investor Resources
- Sign up free to read all 10 articles →
Where BGLC sits on the market map
Services-Medical Laboratories Peers
Companies sharing the same SEC industry code, one row per issuer, largest first - a classification match, not a curated list of competitors.
| Company | AI Signal | Market Cap | P/E |
|---|---|---|---|
| BGLC Bionexus Gene Lab Corp | $3M | – | |
| NTRA Natera, Inc. | $54.62B | – | |
| LH Labcorp Holdings Inc. | $28.74B | 29.0x | |
| DGX Quest Diagnostics Inc | $27.18B | 24.6x | |
| GH Guardant Health, Inc. | $23.48B | – | |
| CAI Caris Life Sciences, Inc. | $9.70B | 7.2x | |
| GRAL Grail, Inc. | $6.23B | – | |
| RDNT Radnet, Inc. | $5.78B | – | |
| BLLN Billiontoone, Inc. | $5.21B | 380.8x | |
| CDNA Caredx, Inc. | $4.52B | 43.9x | |
| VCYT Veracyte, Inc. | $3.94B | 43.0x | |
| CELC Celcuity Inc. | $3.38B | – | |
| FTRE Fortrea Holdings Inc. | $2.02B | – | |
| PSNL Personalis, Inc. | $1.68B | – | |
| FRNM Freenome, Inc. | $1.23B | – | |
| LMRI Lumexa Imaging Holdings, Inc. | $1.08B | – | |
| CSTL Castle Biosciences Inc | $1.07B | – | |
| FLGT Fulgent Genetics, Inc. | $533M | – | |
| BDSX Biodesix Inc | $222M | – | |
| XGN Exagen Inc. | $203M | – | |
| BNR Burning Rock Biotech Ltd | $117M | – | |
| SERA Sera Prognostics, Inc. | $78M | – | |
| MDXH Mdxhealth Sa | $18M | – | |
| AMS American Shared Hospital Services | $8M | – | |
| ACON Aclarion, Inc. | $5M | – | |
| ADVB Advanced Biomed Inc. | $3M | – | |
| RNLXY Renalytix Plc | N/A | – |
FAQ
Is Bionexus Gene Lab Corp a good stock to buy?
Our AI analyzes Bionexus Gene Lab Corp daily. Check the signal above for the latest recommendation. Always do your own research before investing.
How accurate are Bionexus Gene Lab Corp predictions?
For BGLC, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 10.0%, measured on 358 forecast dates between 2022-08-16 and 2026-08-05 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 8.0%, measured on 400 forecast dates between 2022-08-16 and 2026-10-02. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are forecasts updated?
Bionexus Gene Lab Corp forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 3, 2026.
Ready to invest smarter? · Join thousands of investors using AI-powered stock predictions
Sign Up FreeLooking for a deeper analysis of Bionexus Gene Lab Corp? View full institutional-grade analysis on Intratio →
AI predictions are based on historical patterns and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always do your own research.